Objective: To study the cellular immunity function of patients with early syphilis and the effects on immune modifiers Esberitox N or IFN. Methods: T-lymphocyte subpopulations of the peripheral blood in 44 patients wi...Objective: To study the cellular immunity function of patients with early syphilis and the effects on immune modifiers Esberitox N or IFN. Methods: T-lymphocyte subpopulations of the peripheral blood in 44 patients with syphilis and 40 healthy controls were examined by flow cytometry. Results: The number of CD4+ cells and the CD4+/CD8+ ratio in patients with syphilis were found to be significantly lower than those in the control (P<0.01), while the number of CD8+cells was higher than that in the control (P<0.01). The CD4+/CD8+ ratio in those with active disease was lower than that in those who had been cured (P<0.05). The CD4+ count and the CD4+/CD8+ ratio in those treated with antibiotics alone(Penicillin G or Cephalosporins) were lower than those treated with both antibiotics and immunomodulators (P<0.05). Conclusions: Cellular immunity in the patients with early syphilis was prominently suppressed, and treatment with immunomodulators may be helpful for the recovery of cellular immunity of these patients.展开更多
文摘Objective: To study the cellular immunity function of patients with early syphilis and the effects on immune modifiers Esberitox N or IFN. Methods: T-lymphocyte subpopulations of the peripheral blood in 44 patients with syphilis and 40 healthy controls were examined by flow cytometry. Results: The number of CD4+ cells and the CD4+/CD8+ ratio in patients with syphilis were found to be significantly lower than those in the control (P<0.01), while the number of CD8+cells was higher than that in the control (P<0.01). The CD4+/CD8+ ratio in those with active disease was lower than that in those who had been cured (P<0.05). The CD4+ count and the CD4+/CD8+ ratio in those treated with antibiotics alone(Penicillin G or Cephalosporins) were lower than those treated with both antibiotics and immunomodulators (P<0.05). Conclusions: Cellular immunity in the patients with early syphilis was prominently suppressed, and treatment with immunomodulators may be helpful for the recovery of cellular immunity of these patients.